EUVIMEDEUVIMED entdecken
Systematische ÜbersichtVergleichsstudie

Systematic Review of Cellular, Acellular, and Matrix-like Products and Indirect Treatment Comparison Between Cellular/Acellular and Amniotic/Nonamniotic Grafts in the Management of Diabetic Foot Ulcers

Jaideep Banerjee iD, Andrew Lasiter, Leo Nherera

Advances in Wound Care · 01.12.2024 · 13 (12) · 639-651

DOI: 10.1089/wound.2023.0075 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Advances in Wound Care, erschienen am 01.12.2024. Verfasst von Jaideep Banerjee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Smith & Nephew, Fort Worth, Texas, USA. Hauptthemen laut MEDLINE: Diabetic Foot, Wound Healing, Amnion. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant review focuses on the efficacy of cellular, acellular, and matrix-like products (CAMPs) in the management of diabetic foot ulcers (DFUs) based on published randomized controlled trials (RCTs). Recent Advances: Although CAMPs have been incorporated into the clinical algorithm for chronic wounds, evidence is lacking to comparatively evaluate the efficacy of these products. Critical Issues: Level 1 RCT studies are the gold standard to evaluate the efficacy of different treatment approaches; however, due to differences in surgical techniques, patient demographics, and compliance, standard-of-care (SOC) outcomes in the wound care space can vary significantly between different RCTs, making it difficult to compare them against each other. Future Directions: To mitigate variability between different RCTs, wound closure outcomes can be reported as risk ratios (RRs). This review of all the currently published RCTs (with a similar trial design) in patients with DFU and RRs confirms that CAMPs adjunct to SOC result in statistically superior wound closure outcomes in DFUs, when compared with SOC alone, with a RR of 1.72 [1.56, 1.90], p < 0.00001. Enough evidence is still lacking to determine a statistical difference between broad categories of cellular/acellular and amniotic/nonamniotic CAMPs, and hence, decision makers should consider published head-to-head comparative studies, real-world evidence, and cost-effectiveness evidence between individual CAMPs to decide on which to use in practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootWound HealingAmnionHumansRandomized Controlled Trials as TopicAcellular Dermis

Stichwörter der Autor:innen

cellular/acellular CT/P and amniotic and nonamniotic membranesdiabetic foot ulcershuman cell and tissue productsskin substitutes

Autor:innen und Institutionen

  • Smith & Nephew, Fort Worth, Texas, USA.

ORCID-Profile: Jaideep Banerjee

Zitieren

APA

Banerjee, J., Lasiter, A., & Nherera, L. (2024). Systematic Review of Cellular, Acellular, and Matrix-like Products and Indirect Treatment Comparison Between Cellular/Acellular and Amniotic/Nonamniotic Grafts in the Management of Diabetic Foot Ulcers. Advances in Wound Care, 13(12), 639-651. https://doi.org/10.1089/wound.2023.0075

Vancouver

Banerjee J, Lasiter A, Nherera L. Systematic Review of Cellular, Acellular, and Matrix-like Products and Indirect Treatment Comparison Between Cellular/Acellular and Amniotic/Nonamniotic Grafts in the Management of Diabetic Foot Ulcers. Advances in Wound Care. 2024;13(12):639-651. doi:10.1089/wound.2023.0075

BibTeX
@article{Banerjee2024,
  author = {Banerjee, Jaideep and Lasiter, Andrew and Nherera, Leo},
  title = {Systematic Review of Cellular, Acellular, and Matrix-like Products and Indirect Treatment Comparison Between Cellular/Acellular and Amniotic/Nonamniotic Grafts in the Management of Diabetic Foot Ulcers},
  journal = {Advances in Wound Care},
  year = {2024},
  volume = {13},
  number = {12},
  pages = {639--651},
  doi = {10.1089/wound.2023.0075}
}
Kostenlos starten →